secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001159036-25-000022
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme stockholders elect two Class III directors and approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Jeffrey W. Henderson elected with 98,993,463 votes for, 3,298,117 against; Helen I. Torley elected with 101,477,199 for, 816,675 against.
- Say-on-pay proposal approved: 98,252,464 for, 3,966,034 against, 168,127 abstain.
- Ratification of Ernst & Young as 2025 auditor approved: 112,028,211 for, 659,976 against, 78,816 abstain.
- Meeting held May 1, 2025; 112,767,003 shares represented out of 123,533,310 outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000022/0001159036-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000022/halo-20250501.htm
  HTML page:      https://secwatch.observer/filing/0001159036-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer